Monitoring pharmaceutical interventions with conventional ultrasound (IMT)

Carotid Disease: The Role of Imaging in Diagnosis and Management

Volumn 9780521862264, Issue , 2006, Pages 430-450

  Crouse, John R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; NON NEWTONIAN FLOW;

ARTERIAL DISEASE; CARDIO-VASCULAR RISK FACTORS; CAROTID STENOSIS; CLINICAL OUTCOME; CORONARY DISEASE; DOPPLER ULTRASOUND; NON-INVASIVE IMAGING; PARADIGM SHIFTS;

ULTRASONICS;

EID: 84927065026     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511544941.032     Document Type: Chapter

References (171)

1. Ainsworth, C. D., Blake, C. C., Tamayo, A., et al. (2005). 3D ultrasound measurement of change in carotid plaque volume: a tool for rapid evaluation of new therapies. Stroke, 36, 1904-9.
2. Anand, S. S., Yusuf, S., Vuksan, V., et al. (2000). Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet, 356, 279-84.
3. Anand, S. S., Yi, Q., Gerstein, H., et al. (2003). Study of Health Assessment and Risk in Ethnic Groups; Study of Health Assessment and Risk Evaluation in Aboriginal Peoples Investigators. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation, 108, 420-5.
4. Angerer, P., Kothny, W., Stork, S. and von Schacky, C. (2002a). Effect of dietary supplementation with omega-3 fatty acids on progression of atherosclerosis in carotid arteries. Cardiovascular Research, 54, 183-90.
5. Angerer, P., Stork, S., Kothny, W. and von Schacky, C. (2002b). Effect of postmenopausal hormone replacement on atherosclerosis in femoral arteries. Maturitas, 41, 51-60.
6. Barnes, R. W., Bone, G. E., Reinertson, J., et al. (1976). Noninvasive ultrasonic carotid angiography: prospective validation by contrast arteriography. Surgery, 80, 328-35.
7. Black, D. M. (2002). Introduction to conference on vascular imaging. American Journal of Cardiology, 89 (Suppl. B), 1B-3B.
8. Blankenhorn, D. H. and Curry, P. J. (1982). The accuracy of arteriography and ultrasound imaging for atherosclerosis measurement. Archives of Pathology and Laboratory Medicine, 106, 483-9.
9. Blankenhorn, D. H., Selzer, R. H., Crawford, D. W., et al. (1993). Beneficial effects of colestipol-niacin therapy on the common carotid artery. Circulation, 88, 20-8.
10. Bonithon-Kopp, C, Touboul, P. J., Berr, C., Magne, C. and Ducimetiere, P. (1996). Factors of carotid arterial enlargement in a population aged 59 to 71 years. The EVA Study. Stroke, 27, 654-60.
11. Bonithon-Kopp, C, Scarabin, P. Y. and Taquet, A. (1991). Risk factors for early carotid atherosclerosis in middleaged French women. Arteriosclerosis and Thrombosis, 11, 966-72.
12. Boquist, S., Ruotolo, G., Tang, R., et al. (1999). Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men. Circulation, 100, 723-8.
13. Borhani, N. O., Mercuri, M., Borhani, P. A., et al. (1996). Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial. Journal of the American Medical Association, 276, 785-91.
14. Bots, M. L., van Swieten, J. C., Breteler, M. M. B., et al. (1993). Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet, 341, 1232-7.
15. Bots, M. L., de Jong, P. T. V. M., Hofman, A. and Grobbee, D. E. (1997). Left, right, near or far wall common carotid intima-media thickness measurements: associations with cardiovascular disease and lower extremity arterial atherosclerosis. Journal of Clinical Epidemiology, 50, 801-7.
16. Bots, M. L., Hoes, A. W., Koudstaal, P. J., Hofman, A. and Grobbee, D. E. (1997). Common carotid intimamedial thickness and risk of stroke and myocardial infarction. The Rotterdam Study. Circulation, 96, 1432-7.
17. Bots, M. L., Evans, G. W., Riley, W., et al. (2003a). The Osteoporosis Prevention and Arterial effects of Tibolone (OPAL) study: design and baseline characteristics. Controlled Clinical Trials, 24, 752-75.
18. Bots, M. L., Evans, G. W., Riley, W. A. and Grobbee, D. E. (2003b). Carotid intima-media thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view. Stroke, 34, 2985-94.
19. Burke, G. L., Evans, G. W., Riley, W. A., et al. (1995). Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) study. Stroke, 26, 386-91.
20. Byington, R. P., Furberg, C. D., Herrington, D. M., et al. (2002). Heart and Estrogen/Progestin Replacement Study Research Group. Effect of estrogen plus progestin on progression of carotid atherosclerosis in postmenopausal women with heart disease: HERS B-mode substudy. Arteriosclerosis, Thrombosis and Vascular Biology, 22, 1692-7.
21. Cao, J. J., Thach, C., Manolio, T. A., et al. (2003). C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly. The Cardiovascular Health Study. Circulation, 108, 166-70.
22. Chambers, B. R. and Norris, J. W. (1986). Outcome in patients with asymptomatic neck bruits. New England Journal of Medicine, 315, 860-5.
23. Chambless, L. E., Shahar, E., Sharrett, A. R., et al. (1996). Association of transient ischemic attack/stroke symptoms assessed by standardized questionnaire and algorithm with cerebrovascular risk factors and carotid artery wall thickness. American Journal of Epidemiology, 144, 857-66.
24. Chambless, L. E., Heiss, G., Folsom, A. R., et al. (1997). Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) study, 1987-1993. American Journal of Epidemiology, 146, 483-94.
25. Chambless, L. E., Folsom, A. R., Davis, V., et al. (2002). Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1987-1988. American Journal of Epidemiology, 155, 38-47.
26. Chambless, L. E., Folsom, A. R., Sharrett, A. R., et al. (2003). Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study. Journal of Clinical Epidemiology, 56, 880-90.
27. Chambless, L. E., Heiss, G., Shahar, E., Earp, M. J. and Toole, J. (2004). Prediction of ischemic stroke risk in the Atherosclerosis Risk in Communities Study. American Journal of Epidemiology, 160, 259-69.
28. Craven, T. E., Ryu, J. E., Espeland, M. A., et al. (1990). Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis: A case control study. Circulation, 82, 1230-42.
29. Crouse, J. R. (1993). B-mode in clinical trials: Answers and questions. Circulation, 88, 319-21.
30. Crouse, J. R. and Thompson, C. J. (1993). An evaluation of methods for imaging and quantifying coronary and carotid lumen stenosis and atherosclerosis. Circulation, 87 (Suppl. II), 17-33.
31. Crouse, J. R., Byington, R. P., Bond, M. G., et al. (1992). Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries: Design features of a clinical trial with atherosclerosis outcome. Controlled Clinical Trials, 13, 495-506.
32. Crouse, J. R. III, Goldbourt, U., Evans, G., et al. (1994). Arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) Cohort. Stroke, 25, 1354-9.
33. Crouse, J. R., Byington, R. P., Bond, M. G., et al. (1995). Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II). American Journal of Cardiology, 75, 455-9.
34. Crouse, J. R. III, Goldbourt, U., Evans, G., et al. (1996). Risk Factors and Segment Specific Carotid Arterial Enlargement in the Atherosclerosis Risk in Communities (ARIC) Cohort. Stroke, 27, 69-75.
35. Crouse, J. R., Tang, R., Espeland, M. A., et al. (2002). Associations of extracranial carotid atherosclerosis progression with coronary status and risk factors in patients with and without coronary artery disease. Circulation, 106, 2061-6.
36. Crouse, J. R., Grobbee, D. E., O’Leary, D. H., et al. (2004). Measuring effects on intima media thickness: an evaluation of rosuvastatin in subclinical atherosclerosis - the rationale and methodology of the METEOR study. Cardiovascular Drugs and Therapy, 18, 231-8
37. D’Agostino, R. B., Burke, G., O’Leary, D., et al. (1996). Ethnic differences in carotid wall thickness. Stroke, 27, 1744-9.
38. Davies, M. J. (1996). Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. Circulation, 94, 2013-20.
39. De Groot, E., Jukema, J. W., Montauban van Swijndregt, A. D., et al. (1998). B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS). Journal of the American College of Cardiology, 31, 1561-7.
40. De Kleijn, M. J., Bots, M. L., Bak, A. A., et al. (1999). Hormone replacement therapy in perimenopausal women and 2-year change of carotid intima-media thickness. Maturitas, 32, 195-204.
41. Del Sol, A. I., Moons, K. G., Hollander, M., et al. (2001). Is carotid intima-media thickness useful in cardiovascular disease risk assessment? Stroke, 32, 1532-8.
42. Diez-Roux, A V., Nieto, F. J., Comstock, G. W., Howard, G. and Szklo, M. (1995). The relationship of active and passive smoking to carotid atherosclerosis 12-14 years later. Preventive Medicine, 24, 48-55.
43. Duggirala, R., Gonzalez Villalpando, C., O’Leary, D. H., Stern, M. P. and Blangero, J. (1996). Genetic basis of variation in carotid artery wall thickness. Stroke, 27, 833-7.
44. Dwyer, J. H., Paul-Labrador, M. J., Fan, J., et al. (2004). Progression of carotid intima-media thickness and plasma antioxidants: the Los Angeles Atherosclerosis Study. Arteriosclerosis, Thrombosis and Vascular Biology, 24, 313-19.
45. Ebrahim, S., Papacosta, O., Whincup, P., et al. (1999). Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke, 30, 841-50.
46. El-Barghouty, N, Nicolaides, A., Behal, V., Geroulakos, G. and Androulakis, A. (1996). The identification of the high risk carotid plaque. European Journal of Vascular and Endovascular Surgery, 11, 470-8.
47. Espeland, M. A., Craven, T. E., Riley, W. A., et al. (1996). Reliability of longitudinal ultrasonographic measurements of carotid intimal-medial thicknesses. Stroke, 27, 480-5.
48. Espeland, M. A., Tang, R., Terry, J. G., et al. (1999a). Associations of risk factors with segment specific intimal-medial thickness of the extracranial carotid artery. Stroke, 30, 1047-55.
49. Espeland, M. A., Craven, T. E., Miller, M. E. and D’Agostino, R. (1999b). Modeling multivariate longitudinal data that are incomplete. Annals of Epidemiology, 9, 196-205.
50. Espeland, M. A., Evans, G. W., Wagenknecht, L. E., et al. (2003). Site-specific progression of carotid artery intimal-medial thickness. Atherosclerosis, 171, 137-43.
51. Espeland, M. A., O’Leary, D. H., Terry, J. G., et al. (2005). Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors. Current Controlled Trials in Cardiovascular Medicine, 6, 1-6.
52. Fontana, L., Meyer, T. E., Klein, S. and Holloszy, J. O. (2004). Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proceedings of the National Academy of Sciences USA, 101, 6659-63.
53. Fox, C. S., Polak, J. F., Chazaro, I., et al. (2003). Genetic and environmental contributions to atherosclerosis phenotypes in men and women: heritability of carotid intimamedia thickness in the Framingham Heart Study. Stroke, 34, 397-401.
54. Fried, L. P., Kronmal, R. A., Newman, A. B., et al. (1998). Risk factors for 5-year mortality in older adults. The Cardiovascular Health Study. Journal of the American Medical Association, 279, 585-92.
55. Furberg, C. D., Adams, H. P., Applegate, W. B., et al. (1994). Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Circulation, 90, 1679-87.
56. Gamble, G., Beaumont, B., Smith, H., et al. (1993). B-mode ultrasound images of the carotid artery wall: correlation of ultrasound with histological measurements. Atherosclerosis, 102, 163-73.
57. Gariepy, J., Salomon, J., Denarie, N., et al. (1998). Sex and topographic differences in associations between largeartery wall thickness and coronary risk profile in a French working cohort: the AXA Study. Arteriosclerosis, Thrombosis and Vascular Biology, 18, 584-90.
58. Glagov, S., Weisenberg, E., Zarins, C. K., Stankunavicius, R. and Kolettis, G. J. (1987). Compensatory enlargement of human atherosclerotic coronary arteries. New England Journal of Medicine 316, 1371-5.
59. Gnasso, A., Motti, C., Irace, C., et al. (2000). Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects. Arteriosclerosis, Thrombosis and Vascular Biology, 20, 1600-5.
60. Hak, A. E., Stehouwer, C. D., Bots, M. L., et al. (1999). Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arteriosclerosis, Thrombosis and Vascular Biology, 19, 1986-91.
61. Hanefeld, M., Chiasson, J. L., Koehler, C., et al. (2004). Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance. Stroke, 35, 1073-8.
62. Haney, C., Rainforth, M. and Salerno, J. (2000). Effects of stress reduction on carotid atherosclerosis in hypertensive African Americans. Stroke, 31, 568-73.
63. Hedblad, B., Wikstrand, J., Janzon, L., Wedel, H. and Berglund, G. (2001). Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS). Circulation, 103, 1721-6.
64. Heiss, G., Sharrett, A. R., Barnes, R., et al. (1991). Carotid atherosclerosis measured by B-mode ultrasound in populations: Associations with cardiovascular risk factors in the ARIC study. American Journal of Epidemiology, 134, 250-6.
65. Hennerici, M., Aulich, A., Sandmann, W. and Freund, H. J. (1981). Incidence of asymptomatic extracranial arterial disease. Stroke, 12, 750-8.
66. Hodis, H. N., Mack, W. J., LaBree, L., et al. (1996). Reduction in carotid arterial wall thickness using lovastatin and dietary therapy. Annals of Internal Medicine, 124, 549-56.
67. Hodis, H. N., Mack, W. J., LaBree, L., et al. (1998). The role of carotid arterial intima-media thickness in predicting clinical coronary events. Annals of International Medicine, 128, 262-9.
68. Hodis, H. N., Mack, W. J., Lobo, R. A., et al. (2001). Estrogen in the Prevention of Atherosclerosis Trial Research Group. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine, 135, 939-53.
69. Hoogerbrugge, N., de Groot, E., de Heide, L. H., et al. (2002). Doxazosin and hydrochlorothiazide equally affect arterial wall thickness in hypertensive males with hypercholesterolaemia (the DAPHNE study). Doxazosin Atherosclerosis Progression Study in Hypertensives in the Netherlands. The Netherlands Journal of Medicine, 60, 354-61.
70. Howard, G., Sharrett, A. R., Heiss, G., et al. (1993). Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. Stroke, 24, 1297-304.
71. Howard, G., O’Leary, D. H., Zaccaro, D., et al. (1996). Insulin sensitivity and atherosclerosis. Circulation, 93, 1809-17.
72. Howard, G., O’Leary, D. H., Zaccaro, D., et al. (1996). Insulin sensitivity and atherosclerosis. Circulation, 93, 1809-17.
73. Hsue, P. Y., Lo, J. C., Franklin, A., et al. (2004). Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation, 109, 1603-8.
74. Humphries, S. E. and Morgan, L. (2004). Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches. The Lancet Neurology, 3, 227-36.
75. Hunt, K. J., Duggirala, R., Goring, H. H., et al. (2002). Genetic basis of variation in carotid artery plaque in the San Antonio Family Heart Study. Stroke, 33, 2775-80.
76. Hwang, S., Ballantyne, C. M., Sharrett, A. R., et al. (1997). Circulating adhesions molecules VCAM-1, ICAM-1 and E-selectin in carotid atherosclerosis and incident coronary heart disease cases. The Atherosclerosis Risk in Communities (ARIC) Study. Circulation, 96, 4219-25.
77. Jartti, L., Ronnemaa, T., Kaprio, J., et al. (2002). Population-based twin study of the effects of migration from Finland to Sweden on endothelial function and intimamedia thickness. Arteriosclerosis, Thrombosis and Vascular Biology, 22, 832-7.
78. Johnsen, S. H., Fosse, E., Joakimsen, O., et al. (2005). Monocyte count is a predictor of novel plaque formation: a 7-year follow-up study of 2610 persons without carotid plaque at baseline: the Tromso Study. Stroke, 36, 715-19.
79. Josse, M. O., Touboul, P. J., Mas, J. L., Laplane, D. and Bousser, M. G. (1987). Prevalence of asymptomatic internal carotid artery stenosis. Neuroepidemiology, 6, 150-2.
80. Kallikazaros, I., Tsioufis, C., Sideris, S., Stefanadis, C. and Toutouzas, P. (1999). Carotid artery disease as a marker for the presence of severe coronary artery disease in patients evaluated for chest pain. Stroke, 30, 1002-7.
81. Kanters, S. D., Algra, A., van Leeuwen, M. S. and Banga, J. D. (1997). Reproducibility of in vivo carotid intima-media thickness measurements: a review. Stroke, 28, 665-71.
82. Karason, K., Wikstrand, J., Sjostrom, L. and Wendelhag, I. (1999). Weight loss and progression of early atherosclerosis in the carotid artery: a four-year controlled study of obese subjects. International Journal of Obesity and Related Metabolic Disorders, 23, 948-56.
83. Kodama, M., Yamasaki, Y., Sakamoto, K., et al. (2000). Antiplatelet drugs attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes. Thrombosis Research, 97, 239-45.
84. Koga, N., Watanabe, K., Kurashige, Y., Sato, T. and Hiroki, T. (1999). Long-term effects of LDL apheresis on carotid arterial atherosclerosis in familial hypercholesterolaemic patients. Journal of Internal Medicine, 246, 35-43.
85. Lakka, T. A., Lakka, H. M., Salonen, R., Kaplan, G. A. and Salonen, J. T. (2001a). Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men. Atherosclerosis, 154, 497-504.
86. Lakka, T. A., Laukkanen, J. A., Rauramaa, R., et al. (2001b). Cardiorespiratory fitness and the progression of carotid atherosclerosis in middle-aged men. Annals of Internal Medicine, 134, 12-20.
87. Lange, L. A., Bowden, D. W., Langefeld, C. D., et al. (2002). Heritability of carotid artery intima-medial thickness in type 2 diabetes. Stroke, 33, 1876-81.
88. Li, S., Chen, W., Srinivasan, S. R., et al. (2003). Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. Journal of the American Medical Association, 290, 2271-6.
89. Lo, L. Y., Ford, C. S., McKinney, W. M. and Toole, J. F. (1986). Asymptomatic bruit, carotid and vertebrobasilar transient ischemic attacks - a clinical and ultrasonic correlation. Stroke, 17, 65-8.
90. Lonn, E., Yusuf, S., Dzavik, V., et al. (2001). Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation, 103, 919-25.
91. Lynch, J., Krause, N., Kaplan, G., Salonen, R. and Salonen, J. T (1997). Workplace demands, economic reward and progression of carotid atherosclerosis. Circulation, 96, 302-7.
92. Lynch, J., Krause, N., Kaplan, G. A., Salonen, R. and Salonen, J. T. (1997). Workplace demands, economic reward, and progression of carotid atherosclerosis. Circulation, 96, 302-7.
93. Mackinnon, A. D., Jerrard-Dunne, P., Sitzer, M., et al. (2004). Rates and determinants of site-specific progression of carotid artery intima-media thickness: the carotid atherosclerosis progression study. Stroke, 35, 2150-4.
94. Mackinnon, A. D., Jerrard-Dunne, P., Sitzer, M., et al. (2004). Rates and determinants of site-specific progression of carotid artery intima-media thickness: the carotid atherosclerosis progression study. Stroke, 35, 2150-4.
95. MacMahon, S., Sharpe, N., Gamble, G., et al. (1998). Effects of lowering average or below-average cholesterol levels on the progression of carotid atherosclerosis. Results of the LIPID atherosclerosis substudy. Circulation, 98, 1784-90.
96. MacMahon, S., Sharpe, N., Gamble, G., et al. (2000). Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease. PART-2 Collaborative Research Group. Prevention of Atherosclerosis with Ramipril. Journal of the American College of Cardiology, 36, 438-43.
97. Manolio, T. A., Kronmal, R. A., Burke, G. L., et al. (1994). Magnetic resonance abnormalities and cardiovascular disease in older adults. Stroke, 25, 318-27.
98. Manolio, T. A., Kronmal, R. A., Burke, G. L., O’Leary, D. H. and Price, T. R. (1996). Short-term predictors of incident stroke in older adults. The Cardiovascular Health Study. Stroke, 27, 1479-86.
99. Manolio, T. A., Boerwinkle, E., O’Donnell, C. J. and Wilson, A. F. (2004). Genetics of ultrasonographic carotid atherosclerosis. Arteriosclerosis, Thrombosis and Vascular Biology, 24, 1567-77.
100. Marcucci, R., Zanazzi, M., Bertoni, E., et al. (2003). Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renaltransplant recipients. Transplantation, 75, 1551-5.
101. Markussis, V., Beshyah, S. A., Fisher, C., et al. (1992). Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet, 340, 1188-92.
102. Matsumoto, K., Sera, Y., Abe, Y., et al. (2004). Metformin attenuates progression of carotid arterial wall thickness in patients with type 2 diabetes. Diabetes Research and Clinical Practice, 64, 225-8.
103. McNeill, A. M., Rosamond, W. D., Girman, C. J., et al. (2004). Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (The ARIC Study). American Journal of Cardiology, 94, 1249-54.
104. Melnick, S. L., Shahar, E., Folsom, A. R., et al. (1993). Past infection by chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. American Journal of Medicine, 95, 499-504.
105. Mercuri, M., Bond, M. G., Sirtori, C. R., et al. (1996). Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic Mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study. American Journal of Medicine, 101, 627-34.
106. Miyazaki, H., Matsuoka, H., Cooke, J. P., et al. (1999). Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation, 99, 1141-6.
107. Nagata-Sakurai, M, Inaba, M., Goto, H., et al. (2003). Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis. Arthritis and Rheumatism, 48, 3061-7.
108. Nathan, D. M., Lachin, J., Cleary, P., et al. (2003). Diabetes Control and Complications Trial; Epidemiology of Diabetes Interventions and Complications Research Group. Intensive diabetes therapy and carotid intimamedia thickness in type 1 diabetes mellitus. New England Journal of Medicine, 348, 2294-303.
109. Nordstrom, C. K., Dwyer, K. M., Merz, C. N., Shircore, A. and Dwyer, J. H. (2003). Leisure time physical activity and early atherosclerosis: the Los Angeles Atherosclerosis Study. American Journal of Medicine, 115, 19-25.
110. North, K. E., MacCluer, J. W., Devereux, R. B., et al. (2002). Heritability of carotid artery structure and function: the Strong Heart Family Study. Arteriosclerosis, Thrombosis and Vascular Biology, 22, 1698-703.
111. O’Leary, D. H., Polak, J. F., Kronmal, R. A., et al. (1992). Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. Stroke, 23, 1752-60.
112. O’Leary, D. H., Polak, J. F., Kronmal, R. A., et al. (1999). Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. New England Journal of Medicine, 340, 14-22.
113. Pignoli, P., Tremoli, E., Poli, A., Oreste, P. and Paoletti, R. (1986). Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation, 74, 1399-406.
114. Pitt, B., Byington, R. P., Furberg, C. D., et al. (2000). Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation, 102, 1503-10.
115. Polak, J. F., Kronmal, R. A., Tell, G. S., et al. (1996). Compensatory increase in common carotid artery diameter. Stroke, 27, 2012-15.
116. Polak, J. R., Shemanski, L., O’Leary, D. H., et al. (1998). Hypoechoic plaque at US of the carotid artery: an independent risk factor for incident stroke in adults aged 65 years or older. Radiology, 208, 649-54.
117. Postiglione, A., Rubba, P., De Simone, B., et al. (1985). Carotid atherosclerosis in familial hypercholesterolemia. Stroke, 16, 658-61.
118. Price, T. R., Manolio, T. A., Kronmal, R. A., et al. (1997). Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults. Stroke, 28, 1158-64.
119. Psaty, B. M., Furberg, C. D., Kuller, L. H., et al. (1999). Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults. The Cardiovascular Health Study. Archives of Internal Medicine, 159, 1339-47.
120. Raitakari, O. T., Juonala, M., Kahonen, M., et al. (2003). Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. Journal of the American Medical Association, 290, 2277-83.
121. Ranke, C., Hecker, H., Creutzig, A. and Alexander, K. (1993). Dose-dependent effect of aspirin on carotid atherosclerosis. Circulation, 87, 1873-9.
122. Roman, M. J., Shanker, B. A., Davis, A., et al. (2003). Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. New England Journal of Medicine, 349, 2399-406.
123. Sabeti, S., Exner, M., Mlekusch, W., et al. (2005). Prognostic impact of fibrinogen in carotid atherosclerosis: nonspecific indicator of inflammation or independent predictor of disease progression? Stroke, 36, 1400-4.
124. Salomaa V., Stinson V., Kark, J. D., et al. (1995). Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Circulation, 15, 1269-79.
125. Salonen, R. and Salonen, J. T. (1990). Progression of carotid atherosclerosis and its determinants: a population-based ultrasonography study. Atherosclerosis, 81, 33-40.
126. Salonen, J. T. and Salonen, R. (1993). Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation, 87 (Suppl. II), II-56-II.
127. Salonen, R., Seppanen, K., Rauramaa, R. and Salonen, J. T. (1988). Prevalence of carotid atherosclerosis and serum cholesterol levels in eastern Finland. Arteriosclerosis, 8, 788-92.
128. Salonen, R., Tervahauta, M., Salonen, J. T., et al. (1994). Ultrasonographic manifestations of common carotid atherosclerosis in elderly Eastern Finnish men. Arteriosclerosis and Thrombosis, 14, 1631-40.
129. Salonen, R., Nyyssonen, K., Porkkala, E., et al. (1995). Kuopio Atherosclerosis Prevention Study (KAPS). Circulation, 92, 1758-64.
130. Salonen, R. M., Nyyssonen, K., Kaikkonen, J., et al. (2003). Antioxidant Supplementation in Atherosclerosis Prevention Study. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation, 107, 947-53.
131. Sawayama, Y., Shimizu, C., Maeda, N., et al. (2002). Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia. Fukuoka Atherosclerosis Trial (FAST). Journal of the American College of Cardiology, 39, 610-16.
132. Schillinger, M., Exner, M., Mlekusch, W., et al. (2005). Inflammation and Carotid Artery - Risk for Atherosclerosis Study (ICARAS). Circulation, 111, 2203-9.
133. Schott, L. L., Wildman, R. P., Brockwell, S., et al. (2004). Segment-specific effects of cardiovascular risk factors on carotid artery intima-medial thickness in women at midlife. Arteriosclerosis, Thrombosis and Vascular Biology, 24, 1951-6.
134. Selhub, J., Jacques, P. F., Bostom, A. G., et al. (1995). Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. New England Journal of Medicine, 332, 286-91.
135. Sharrett, A. R., Sorlie, P. D., Chambless, L. E., et al. (1999). Relative importance of various risk factors for asymptomatic carotid atherosclerosis versus coronary heart disease incidence. American Journal of Epidemiology, 149, 843-52.
136. Sidhu, J. S., Kaposzta, Z., Markus, H. S. and Kaski, J. C. (2004). Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus. Arteriosclerosis, Thrombosis and Vascular Biology, 24, 930-4.
137. Simon, A., Gariepy, J., Moyse, D. and Levenson, J. (2001). Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes. Circulation, 103, 2949-54.
138. Smilde, T. J., van Wissen, S., Wollersheim, H., et al. (2001). Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomized, doubleblind trial. Lancet, 357, 577-81.
139. Swan, L., Birnie, D. H., Inglis, G., Connell, J. M. and Hillis, W. S. (2003). The determination of carotid intima medial thickness in adults - a population-based twin study. Atherosclerosis, 166, 137-41.
140. Sztajzel, R., Momjian, S., Momjian-Mayor, I., et al. (2005). Stratified gray-scale median analysis and color mapping of the carotid plaque: correlation with endarterectomy specimen histology of 28 patients. Stroke, 36, 741-5.
141. Tang, R., Hennig, M., Thomasson, B., et al. (2000). Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness: the European Lacidipine Study on Atherosclerosis (ELSA). Journal of Hypertension, 18, 197-201.
142. Taylor, A. J., Kent, S. M., Flaherty, P. J., et al. (2002). ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation, 106, 2055-60.
143. Taylor, A. J., Sullenberger, L. E., Lee, H. J., Lee, J. K. and Grace, K. A. (2004). Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation, 110, 3512-17.
144. Tell, G. S., Evans, G. W., Folsom, A. R., et al. (1994). Dietary fat intake and carotid artery wall thickness: The Atherosclerosis Risk in Communities (ARIC) Study. American Journal of Epidemiology, 139, 979-89.
145. Terry, J. G., Tang, R., Espeland, M. A., et al. (2003). Carotid arterial structure in patients with documented coronary artery disease and disease-free control subjects. Circulation, 107, 1146-51.
146. Tracy, R. P., Bovill, E. G., Yanez, D., et al. (1995). Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly. Results from the Cardiovascular Health Study. Arteriosclerosis, Thrombosis and Vascular Biology, 15, 1269-79.
147. Van der Meer, I. M., de Maat, M. P., Bots, M. L., et al. (2002). Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis: the Rotterdam Study. Arteriosclerosis, Thrombosis and Vascular Biology, 22, 838-42.
148. Van der Meer, I. M., de Maat, M. P., Hak, A. E., et al. (2002). C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: the Rotterdam Study. Stroke, 33, 2750-5.
149. Van der Meer, I. M., Iglesias del Sol, A., Hak, A. E., et al. (2003). Risk factors for progression of atherosclerosis measured at multiple sites in the arterial tree: the Rotterdam Study. Stroke, 34, 2374-9.
150. Van der Meer, I. M., Iglesias del Sol, A., Hak, A. E., et al. (2003). Risk factors for progression of atherosclerosis measured at multiple sites in the arterial tree: the Rotterdam Study. Stroke, 34, 2374-9.
151. Vermeer, S. E., Den Heijer, T., Koudstaal, P. J., et al. (2003). Rotterdam Scan Study. Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke, 34, 392-6.
152. Vermeulen, E. G., Stehouwer, C. D., Twisk, J. W., et al. (2000). Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. Lancet, 355, 517-22.
153. Wallenfeldt, K., Bokemark, L., Wikstrand, J., Hulthe, J. and Fagerberg, B. (2004). Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men. Stroke, 35, 2248-52.
154. Wallenfeldt, K., Hulthe, J. and Fagerberg, B. (2005). The metabolic syndrome in middle-aged men according to different definitions and related changes in carotid artery intima-media thickness (IMT) during 3 years of follow-up. Journal of Internal Medicine, 258, 28-37.
155. Wang, T. J., Nam, B. H., Wilson, P. W., et al. (2002). Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. Arteriosclerosis, Thrombosis and Vascular Biology, 22, 1662-7.
156. Wiklund, O., Hulthe, J., Wikstrand, J., et al. (2002). Effect of controlled release/extended release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia: a 3-year randomized study. Stroke, 33, 572-7.
157. Wildman, R. P., Schott, L. L., Brockwell, S., Kuller, L. H. and Sutton-Tyrrell, K. (2004). A dietary and exercise intervention slows menopause-associated progression of subclinical atherosclerosis as measured by intimamedia thickness of the carotid arteries. Journal of the American College of Cardiology, 44, 579-85.
158. Willeit, J., Kiechl, S., Oberhollenzer, F., et al. (2000). Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study. Arteriosclerosis, Thrombosis and Vascular Biology, 20, 529-37.
159. Willeit, J., Kiechl, S., Oberhollenzer, F., et al. (2000). Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study. Arteriosclerosis, Thrombosis and Vascular Biology, 20, 529-37.
160. Wilson, P. W. F., Hoeg, J. M., D’Agostino, R. B., et al. (1997). Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis. New England Journal of Medicine, 337, 516-22.
161. Wong, M., Edelstein, J., Wollman, J. and Bond, M. G. (1993). Ultrasonic-pathological comparison of the human arterial wall. Arteriosclerosis and Thrombosis, 13, 482-6.
162. Wu, H., Dwyer, K. M., Fan, Z., et al. (2003). Dietary fiber and progression of atherosclerosis: the Los Angeles Atherosclerosis Study. American Journal of Clinical Nutrition, 78, 1085-91.
163. Xiang, A. H., Azen, S. P., Buchanan, T. A., et al. (2002). Heritability of subclinical atherosclerosis in Latino families ascertained through a hypertensive parent. Arteriosclerosis, Thrombosis and Vascular Biology, 22, 843-8.
164. Zanchetti, A., Rosei, E. A., Dal Palu, C., et al. (1998). The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness. Journal of Hypertension, 16, 1667-76.
165. Zanchetti, A., Bond, M. G., Hennig, M., et al. (2002). European Lacidipine Study on Atherosclerosis investigators. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. Circulation, 106, 2422-7.
166. Zanchetti, A., Bond, M. G., Hennig, M., et al. (2004). Absolute and relative changes in carotid intimamedia thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA). Journal of Hypertension, 22, 1201-12.
167. Zanchetti, A., Crepaldi, G., Bond, M. G., et al. (2004). Different Effects of Antihypertensive Regimens Based on Fosinopril or Hydrochlorothiazide With or Without Lipid Lowering by Pravastatin on Progression of Asymptomatic Carotid Atherosclerosis: Principal Results of PHYLLIS - A Randomized Double-Blind Trial. Stroke, 35, 2807-12.
168. Zannad, F., Visvikis, S., Gueguen, R., et al. (1998). Genetics strongly determines the wall thickness of the left and right carotid arteries. Human Genetics, 103, 183-8.
169. Zannad, F. and Benetos, A. (2003). Genetics of intimamedia thickness. Current Opinion in Lipidology, 14, 191-200.
170. Zureik, M., Touboul, P. J., Bonithon-Kopp, C., et al. (1991). Cross-sectional and 4-year longitudinal associations between brachial pulse pressure and common carotid intima-media thickness in a general population. The EVA study. Stroke, 30, 550-5.
171. Zureik, M., Touboul, P. J., Bonithon-Kopp, C., et al. (1999). Cross-sectional and 4-year longitudinal associations between brachial pulse pressure and common carotid intima-media thickness in a general population. The EVA study. Stroke, 30, 550-5.